Literature DB >> 8487445

An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team.

G L Lu-Yao1, D McLerran, J Wasson, J E Wennberg.   

Abstract

OBJECTIVES: To examine temporal trends and geographic variation in radical prostatectomy rates and short-term outcomes.
DESIGN: Population-based study of radical prostatectomy for the years 1984 through 1990. Poisson regression was used to estimate temporal and regional effects.
SETTING: The 50 states and the District of Columbia. PARTICIPANTS: A 20% national sample of male Medicare beneficiaries aged 65 years or older. MAIN OUTCOME MEASURES: Rate of radical prostatectomy; 30-day mortality; and major cardiopulmonary complications, vascular complications, or surgical repairs within 30 days of radical prostatectomy.
RESULTS: A total of 10,598 radical prostatectomies were identified. The adjusted rate of radical prostatectomy in 1990 was 5.75 times that in 1984. The relative increase was similar in all age groups. Substantial geographic variation existed in rates from 1988 through 1990: all states in the New England and Mid-Atlantic regions had rates equal to or below 60 per 100,000 male Medicare beneficiaries, while all states in the Pacific and Mountain regions had rates equal to or above 130 per 100,000. The mortality and morbidity after radical prostatectomy are not trivial for older men (aged 75 years and older)--almost 2% died and nearly 8% suffered major cardiopulmonary complications within 30 days of the operation.
CONCLUSION: The sharp increase and wide geographic variation in radical prostatectomy rates make the evaluation of this surgical procedure a pressing issue. The rising rate of radical prostatectomy among men aged 75 years and older merits special attention.

Entities:  

Mesh:

Year:  1993        PMID: 8487445     DOI: 10.1001/jama.269.20.2633

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  50 in total

1.  Patterns of prostate cancer treatment by clinical stage and age.

Authors:  D Meltzer; B Egleston; I Abdalla
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 2.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

3.  You can't leap a chasm in two jumps: The Institute of Medicine health care quality report.

Authors:  G D Schiff; Q D Young
Journal:  Public Health Rep       Date:  2001 Sep-Oct       Impact factor: 2.792

4.  Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection.

Authors:  B Schweitzer; S Wiltshire; J Lambert; S O'Malley; K Kukanskis; Z Zhu; S F Kingsmore; P M Lizardi; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  Prostate cancer: 12. The economic burden.

Authors:  S A Grover; H Zowall; L Coupal; M D Krahn
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

6.  Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.

Authors:  L Penberthy; S M Retchin; M K McDonald; D K McClish; C E Desch; G F Riley; T J Smith; B E Hillner; C J Newschaffer
Journal:  Health Care Manag Sci       Date:  1999-07

7.  Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut.

Authors:  Grace Lu-Yao; Peter C Albertsen; Janet L Stanford; Therese A Stukel; Elizabeth S Walker-Corkery; Michael J Barry
Journal:  BMJ       Date:  2002-10-05

8.  Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Authors:  Sigrid Carlsson; Andrew J Vickers; Monique Roobol; James Eastham; Peter Scardino; Hans Lilja; Jonas Hugosson
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

9.  Length of ICU stay for chronic obstructive pulmonary disease varies among large community hospitals.

Authors:  Sean P Keenan; Peter Dodek; Keith Chan; Robert S Hogg; Kevin J P Craib; Aslam H Anis; John J Spinelli
Journal:  Intensive Care Med       Date:  2003-03-15       Impact factor: 17.440

10.  Variation in outpatient antibiotic prescribing in the United States.

Authors:  Michael A Steinman; Katherine Y Yang; Sepheen C Byron; Judith H Maselli; Ralph Gonzales
Journal:  Am J Manag Care       Date:  2009-12       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.